ArticleeNeurologicalSci2022

High-dose immunoglobulin-dependent chronic demyelinating inflammatory polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis.

Satomi Hiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.